HOWEVER THE ENDED EGFR BINDING PROTEINS

• 收藏
• 分享

专利权人:

NAVIGO PROTEINS GMBH

发明人:

BOSSE-DOENECKE, Eva,SETTELE, Florian,FIEDLER, Erik,HAUPTS, Ulrich

申请号：

DK16702945

公开号：

DK3253785T3

申请日:

2016.02.04

申请国别(地区):

DK

年份:

2019

代理人:

摘要：

The present invention relates to new EGFR binding molecules based on ubiquitin muteins (Affilin®), preferably Affilin molecules having a characteristic three amino acid residue motif. The invention further refers to EGFR binding molecules that bind to different or non-overlapping epitopes than the anti-EGFR monoclonal antibody Cetuximab. The invention further relates to the use of these EGFR binding proteins in medicine, preferably for use in the diagnosis or treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/